Authors:
Monali Tayade, Shishanka Wangnoo
Download free PDF
Veterinary Video Endoscopes Market Size & Share 2026-2035
Report ID: GMI10310
|
Published Date: August 2026
|
Report Format: PDF/Excel/Dashboard/Platform
Download Free PDF
Explore Our Licensing Options:
Download Free PDF
Veterinary Video Endoscopes Market
Get a free sample of this report
What are you hoping to find?
Your PDF is on its way. Tell us little about your research goal, and we'll help you find the most relevant market insights.
Veterinary Video Endoscopes Market Size
The veterinary video endoscopes market was valued at USD 138.8 million in 2025 and is projected to reach USD 254 million by 2035, expanding at a 6.4% CAGR from 2026 to 2035. According to the latest report published by Global Market Insights Inc., the market sits at the intersection of companion-animal spending, minimally invasive care, and imaging-system modernization.
Veterinary Video Endoscopes Market Key Takeaways
Market Leader: KARL STORZ SE & Co. KG led with over 14% market share in 2025.
Leading Players: Top 5 players in this market include KARL STORZ, Olympus, Fujifilm, HOYA (Pentax Medical), Richard Wolf, which collectively held a market share of 45% in 2025.
Video endoscopy is moving from a specialist-only capability toward a more repeatable diagnostic workflow in referral hospitals, corporate clinic groups, and selected general practices. The strongest revenue effect comes from systems that pair high-definition visualization with the workflow infrastructure to archive, review, and share images.
The market includes veterinary video processors, flexible and rigid endoscopes, light sources, monitors, integrated towers, portable systems, procedure-specific instruments, reprocessing supplies, and picture archiving and communication system (PACS) software used in animal diagnosis and minimally invasive surgery. It excludes imaging modalities that do not use endoscopic visualization and general veterinary services revenue. The 2025 base estimate follows revenue-share analysis across product, animal type, application, procedure, end-use, and regional demand, with cross-checks against supplier positioning, clinic investment patterns, and procedure demand. Historic coverage spans 2022–2024; the forecast period runs from 2026 through 2035.
Equipment held 52.1% of 2025 revenue as clinics upgraded legacy visualization infrastructure. Consumables and accessories held 28.5% and will expand at 6.8% CAGR as biopsy forceps, retrieval devices, cytology brushes, irrigation products, and reprocessing supplies rise with the installed base. PACS software represented 19.4% and will grow at 6.1%, supported by multi-clinician image management and remote consultation workflows.
GMI Analyst View
The market will expand on utilization rather than on a single hardware replacement cycle through 2035. Better visualization raises the clinical value of each procedure, while portable systems widen access where a full tower cannot be justified. That combination makes service, software connectivity, and consumable availability more material to supplier selection than optics alone. By 2028, purchasing decisions will increasingly separate suppliers that can support image workflow and training from those competing primarily on device specifications.
Key Drivers
Growing Pet Ownership and Expenditure
Approximately 95 million U.S. households owned at least one pet in 2025. Dog ownership reached 53% of U.S. households, or 71 million households, and cat ownership reached 39%, or 53 million households. U.S. pet industry expenditure reached USD 158 billion, including USD 41 billion in veterinary care.[1]American Pet Products Association, 2025 Pet Industry Expenditures and Ownership Statistics - americanpetproducts.org Larger companion-animal populations bring more animals into chronic-disease workups, and owner willingness to authorize advanced diagnostics raises endoscopy utilization in referral settings. The effect is strongest where clinic networks can convert greater case flow into standardized imaging pathways.
Technological Advancements in Veterinary Endoscopy
HD and 4K platforms improve visualization of mucosal irregularities, early lesions, and vascular anomalies. AI-enabled image review and real-time annotation extend that clinical gain by helping operators identify regions that need closer examination. KARL STORZ completed its acquisition of Asensus Surgical in August 2024 for approximately USD 93.45 million, adding digital surgical intelligence and robotics-augmented visualization to its broader endoscopy portfolio.[2]KARL STORZ press release, KARL STORZ Completes Acquisition of Asensus Surgical - globenewswire.com The transaction shows how digital capability has become part of endoscopy platform strategy rather than a separate software category.
Growing Shift Toward Minimally Invasive Procedures
Minimally invasive surgery (MIS) reduces the role of open approaches in diagnostic and surgical care across small and large animals. Peer-reviewed veterinary research indicates that robotic and laser-assisted minimally invasive systems can reduce postoperative recovery time by 30-50% versus conventional open surgery.[3]BMC Veterinary Research, Veterinary Minimally Invasive Surgery Research - springer.com Abdominal/GI tract and urogenital procedures receive the clearest utilization benefit because endoscopy can support diagnosis, biopsy, intervention, and follow-up with less invasive access. Procedure growth also increases demand for single-use and reprocessing consumables.
Growing Prevalence of Chronic and Complex Animal Diseases
Gastrointestinal disorders, respiratory disease, and urogenital pathologies create recurring demand for visualization and biopsy. WOAH documents rising animal-health burdens and added diagnostic complexity associated with transboundary pathogens and antimicrobial resistance.[4]World Organisation for Animal Health, State of the Worlds Animal Health 2025 - woah.org In production-animal and equine settings, reproductive evaluation and respiratory monitoring widen the addressable base beyond companion-animal care. The result is a broader mix of flexible and procedure-specific systems.
Key Restraints
Limited Affordability in Smaller Clinics
Full veterinary video-endoscopy configurations typically cost USD 15,000-50,000. Maintenance, scope repair, reprocessing consumables, and service contracts raise total operating cost after procurement. Smaller independent clinics can struggle to justify a fixed installation when procedure volume is intermittent, particularly in Asia Pacific, Latin America, and the Middle East and Africa. Portable systems priced at USD 8,000-20,000 reduce the entry threshold, but they do not eliminate the need for training, accessories, and ongoing maintenance. The practical restraint is therefore a utilization equation, not the equipment price alone.
Complex Sterilization and Infection Control Requirements
Endoscope reprocessing requires disciplined cleaning, sterilization, storage, and documentation. These requirements create labor and workflow pressure for small practices and raise the value of suppliers with infection-prevention support. STERIS plc and Endo-i operate at this intersection through reprocessing and workflow-management capability. Delays or inconsistencies in reprocessing reduce the availability of installed equipment and can undermine procedure economics.
Shortage of Skilled Veterinary Professionals
The USDA designated 243 rural veterinary shortage areas across 46 U.S. states in 2025.[5]U.S. Department of Agriculture, Veterinary Services Shortage Situations - usda.gov The Bureau of Labor Statistics projects approximately 4,300 veterinarian job openings annually over the next decade.[6]U.S. Bureau of Labor Statistics, Occupational Outlook Handbook: Veterinarians - bls.gov Workforce pressure constrains the use of complex systems where practices lack trained clinicians, technicians, or protected procedure time. Training-oriented systems and AI-supported image review mitigate part of the constraint, but neither replaces the need for capable operators.
GMI Analyst View
Growth constraints will not halt adoption, but they will determine the product mix. Fixed high-end towers will remain concentrated in specialty and referral care, while portable systems and service-led offerings will carry a larger share of new access. Primary research conducted across 280 veterinary clinic directors in North America and Western Europe in Q1 2026 found that 58% ranked image-quality improvement as the leading reason for planned equipment upgrades. This preference indicates that affordability matters most when a system cannot demonstrate a visible clinical upgrade. Through 2030, training and reprocessing support will remain material differentiators for suppliers pursuing independent and rural practices.
Veterinary Video Endoscopes Market Segment Analysis
By Product
Equipment includes video processors, flexible and rigid scopes, light sources, monitors, and integrated towers. It led the market with 52.1% share and will grow at 6.3% CAGR as standard-definition systems give way to HD and 4K platforms. The SonoScape 4K MIS Surgical Endoscopy System addresses high-fidelity surgical-hospital demand, while KARL STORZ TELE PACK VET X addresses compact deployment. Flexible scopes support GI tract, respiratory, and urogenital work; rigid systems support laparoscopy, arthroscopy, and otoscopy. Corporate hospital groups can accelerate replacement cycles through centralized procurement.
Consumables and accessories will grow fastest at 6.8% CAGR. Biopsy forceps, retrieval baskets, cytology brushes, irrigation catheters, and reprocessing chemicals create repeat revenue that does not depend on a new tower sale. PACS software will advance at 6.1% CAGR as DICOM-compatible platforms support image archiving, remote review, and telemedicine consultation. The VUEES system and supplier-provided PACS modules illustrate the shift from isolated procedure equipment to connected imaging workflows.
By Animal Type
Small animals held 65.1% share and will grow at 6.7% CAGR. Dogs and cats generate the largest procedure volume for GI tract, respiratory, and urogenital examinations because chronic enteropathy, inflammatory bowel disease, nasal discharge, and urinary disease create repeat diagnostic demand. KARL STORZ flexible video gastroscopes and Olympus VISERA systems are used in veterinary teaching hospitals and corporate groups. Owner engagement and referral pathways sustain utilization in this segment.
Large animals represented 34.9% share and will grow at 6.0% CAGR. Equine upper-airway, tracheal, and bronchoalveolar evaluation remains a high-volume use case because respiratory performance has direct commercial value in working and sport horses. The EndoSound system, built on an Olympus radial probe fiberscope, received FDA 510(k) clearance in 2024 for veterinary applications. IMV Imaging and Endo-i serve equine and production-animal needs with systems adapted to larger anatomy and field conditions.
By Application
Diagnostic procedures held 72.8% share and will grow at 6.3% CAGR. Flexible video endoscopy supports examination of GI, respiratory, urogenital, and ENT conditions without open intervention. KARL STORZ flexible video gastroscopes and Fujifilm ELUXEO-adapted scopes support upper-GI evaluations and biopsy sampling. AI-assisted mucosal mapping can shorten review time and increase the number of diagnostic cases a practitioner can manage in a day.
Surgical procedures held 27.2% share and will grow faster at 6.8% CAGR. Laparoscopy, cystoscopy, thoracoscopy, and arthroscopy are moving beyond specialist referral centers as general practices adopt less invasive alternatives for ovariectomy, gastropexy, and liver biopsy. Richard Wolf rigid systems and VetOvation MIS toolkits serve this requirement. Surgical growth has a second-order effect: each intervention raises use of trocars, tubing, and single-use instrument tips, reinforcing consumables demand.
By Procedure
Abdominal/GI tract procedures led with 33.0% share and will grow at 6.6% CAGR. Upper-GI endoscopy, colonoscopy, and laparoscopy address chronic vomiting, protein-losing enteropathy, inflammatory bowel disease, and foreign-body cases. KARL STORZ and Olympus flexible video gastroscopes with biopsy channels provide the core equipment base. Companion-animal owners increasingly authorize sequential workups that combine endoscopy, imaging, and histopathology.
Respiratory procedures held 25.2% share and will grow at 6.2% CAGR, supported by bronchoscopy, rhinoscopy, and equine upper-airway evaluation. Urogenital procedures held 20.4% and will expand at 6.8% CAGR as cystoscopy, urethroscopy, laser lithotripsy, and urethral stent placement displace open approaches in referral care. ENT held 15.0% and will grow at 6.0% CAGR; Firefly Global portable otoscopes and Richard Wolf rigid ENT scopes serve this category. Other procedures represented 6.5%, including thoracoscopy, arthroscopy, and early neurological applications.
By End Use
Veterinary hospitals and clinics held 60.1% share and will grow at 6.3% CAGR. The AVMA estimates that 25-30% of U.S. veterinary practices, including roughly 75% of specialty clinics, are owned by large corporations or private equity firms.[7]American Veterinary Medical Association, Veterinary Profession and Pet Ownership Data - avma.org Group operators standardize imaging protocols and negotiate centralized procurement with suppliers including KARL STORZ and Olympus. University teaching hospitals also operate as referral centers and early-adoption sites for systems such as MediCapture VUEES University Edition.
Veterinary diagnostic centers held 24.6% share and will grow fastest at 6.9% CAGR. Their referral model allows general practices to access endoscopy and imaging without owning full systems. MDS Incorporated (MDS Vet) and IMV Imaging serve these multi-modality environments with imaging and information-management offerings. Other end users held 15.4% and will grow at 6.0%, led by research institutions, veterinary schools, government services, and wildlife programs that need specialized scopes and field-deployable configurations.
GMI Analyst View
Segment growth will be shaped by workflow intensity, not by animal type alone. Surgical and urogenital expansion increases consumable use, while diagnostic endoscopy benefits more directly from AI-assisted review and PACS connectivity. Hospitals and diagnostic centers will capture the earliest benefit because they can spread training and reprocessing costs across more cases. By 2030, portable systems will broaden access, but referral facilities will retain the largest role in high-complexity procedures.
Veterinary Video Endoscopes Market Regional Analysis
North America
North America held 40.8% of global revenue in 2025. The United States generated the majority of regional demand, with veterinary services reaching USD 41 billion within a USD 158 billion pet industry. AVMA data placed U.S. pet-owning households at 77.5 million in 2025 and the dog population at 87.3 million. Canada contributes through urban corporate clinic networks and referral facilities. Rural workforce shortages limit access outside metropolitan areas, but specialty hospitals continue to invest in advanced imaging.
Europe
Europe held 27.7% share and will grow at 6.3% CAGR. Germany, the UK, and France lead regional value, supported by companion-animal demand, equipment manufacturing, and clinical training infrastructure. KARL STORZ and Richard Wolf maintain their German base, while European harmonization under Directive 2001/82/EC and the Veterinary Medicinal Products Regulation supports a consistent operating environment.[8]European Commission Directorate-General for Health and Food Safety, Veterinary Medicinal Products Framework - ec.europa.eu FEDIAF estimates more than 100 million pet cats and dogs across the EU and UK.[9]European Pet Food Industry Federation, Facts and Figures - fediaf.org Spain, Italy, and the Netherlands add demand through specialty care and distribution networks, while UK continuing-education requirements support minimally invasive procedure capability.
Asia Pacific
Asia Pacific will grow fastest at 7.0% CAGR. China, India, Japan, South Korea, and Australia represent the approved regional coverage, with China and India central to volume growth and Japan and South Korea positioned toward technology adoption. China had an estimated pet dog and cat population above 130 million in 2025. India’s livestock population was approximately 536 million, supporting large-animal respiratory and reproductive use cases.[10]Food and Agriculture Organization of the United Nations, Livestock Statistics - fao.org H2 2025 primary research across 38 veterinary hospital facilities in China, Japan, India, and South Korea found that 61% were evaluating HD/4K upgrades, with image quality and AI compatibility as the two leading criteria. Australia supports procurement demand through specialist and teaching-hospital care.
Latin America
Brazil, Mexico, and Argentina form the approved country coverage for Latin America. Brazil is one of the three emerging countries with strongest near-term development potential. Capital affordability and financing availability remain binding constraints, favoring portable and price-accessible systems over fixed premium towers. Diagnostic capacity is likely to develop first in metropolitan referral networks, then extend into broader companion-animal and livestock settings.
Middle East and Africa
South Africa, Saudi Arabia, and the UAE form the approved Middle East and Africa coverage. Market expansion depends on clinic investment, specialist availability, and access to maintenance and reprocessing support. Smaller practices face a sharper affordability barrier than major referral centers. Portable systems and distributor-led service models can improve reach where fixed-system throughput is insufficient.
GMI Analyst View
Regional demand follows three different patterns: established replacement demand in North America and Europe, volume and infrastructure expansion in Asia Pacific, and access-led adoption in Latin America and the Middle East and Africa. Asia Pacific will remain the fastest-growing regional market through 2035 because companion-animal and livestock care create two demand bases rather than one. Still, the addressable opportunity will convert unevenly where financing and trained operator capacity lag equipment availability. Suppliers that combine distribution with training, service, and portable configurations will have an advantage outside established referral networks.
Veterinary Video Endoscopes Market Share & Competitive Landscape
The five leading suppliers held approximately 45% of global revenue in 2025, making the market moderately concentrated at the top tier. KARL STORZ led with an estimated 14% share. Its portfolio covers more than 13,000 human and veterinary products, with operations across Germany, the U.S., Switzerland, and Estonia and reported fiscal 2023 revenue of EUR 2.17 billion. Olympus, Fujifilm, HOYA through Pentax Medical, and Richard Wolf complete the leading group. The remaining 55% is distributed across specialist and regional suppliers.
KARL STORZ combines flexible and rigid endoscopy, optical engineering, continuing education, and digital surgical intelligence. The August 2024 Asensus acquisition strengthens its position in robotics and computer-augmented vision. Olympus contributes flexible endoscopy and VISERA imaging capability, including work associated with the EndoSound veterinary endoscopic ultrasound system. Fujifilm spans flexible scopes, processors, PACS, and ELUXEO imaging technologies. HOYA/Pentax Medical focuses on flexible GI and respiratory scopes with durable designs and reprocessing economics. Richard Wolf remains differentiated in rigid laparoscopy, cystoscopy, arthroscopy, and otoscopy.
Major players operating in the veterinary video endoscopes market include:
Biovision Veterinary Endoscopy and Dr. Fritz Endoscopes compete through veterinary-specific product and service focus. Eickemeyer Medizintechnik für Tierärzte serves regional veterinary equipment needs. IMV Imaging has a strong equine and production-animal imaging position in the UK and continental Europe. MDS Vet addresses North American diagnostic-center requirements. Firefly Global supports mobile and rural use cases with portable HD camera systems, while VetOvation combines laparoscopic MIS tools with training support. STERIS and Endo-i address reprocessing and infection-control requirements that become more important as procedure volume rises.
Digital integration will become the central competitive variable as optical performance converges. PACS connectivity, AI-enabled workflows, remote support, and training will determine whether suppliers can convert product installations into repeat utilization. Primary research with six senior competitive-intelligence professionals in Q4 2025 identified digital integration as the expected principal competitive battleground through the next five years. The KARL STORZ–Asensus transaction provides an M&A precedent, and future activity is likely to target AI imaging, portable technology, and veterinary consumable capabilities.
Recent Industry Developments
Need a specific section of this report?
Purchase regional analysis, country-level analysis, company profiles, or any other segment-level insights separately
based on your research needs.
Frequently Asked Question(FAQ) :
Research methodology, data sources & validation process
This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.
Our 6-step research process
1. Research design & analyst oversight
At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.
Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.
2. Primary research
Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.
3. Data mining & market analysis
Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.
4. Market sizing
Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.
5. Forecast model & key assumptions
Every forecast includes explicit documentation of:
✓ Key growth drivers and their assumed impact
✓ Restraining factors and mitigation scenarios
✓ Regulatory assumptions and policy change risk
✓ Technology adoption curve parameter
✓ Macroeconomic assumptions (GDP growth, inflation, currency)
✓ Competitive dynamics and market entry/exit expectations
6. Validation & quality assurance
The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.
Our triple-layer validation process ensures maximum data reliability:
✓ Statistical Validation
✓ Expert Validation
✓ Market Reality Check
Trust & credibility
Verified data sources
Trade publications
Industry journals, trade publications, and specialized media.
Industry databases
Proprietary and third-party market databases
Regulatory filings
Government procurement records and policy documents
Academic research
University studies and specialist institution reports
Company reports
Annual reports, investor presentations, and filings
Expert interviews
C-suite, procurement leads, and technical specialists
GMI archive
13,000+ published studies across 20+ industry verticals
Trade data
Import/export volumes, HS codes, and customs records
Parameters studied & evaluated
Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →